ProShare Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $406K | Buy |
4,712
+1
| +0% | +$90 | ﹤0.01% | 1172 |
|
|
2025
Q4 | $411K | Sell |
4,711
-372
| -7% | -$28.2K | ﹤0.01% | 1249 |
|
|
2025
Q3 | $291K | Sell |
5,083
-265
| -5% | -$15.3K | ﹤0.01% | 1443 |
|
|
2025
Q2 | $316K | Sell |
5,348
-4,730
| -47% | -$306K | ﹤0.01% | 1410 |
|
|
2025
Q1 | $738K | Buy |
10,078
+4,564
| +83% | +$377K | ﹤0.01% | 909 |
|
|
2024
Q4 | $456K | Buy |
5,514
+321
| +6% | +$25.3K | ﹤0.01% | 1330 |
|
|
2024
Q3 | $372K | Sell |
5,193
-387
| -7% | -$27.3K | ﹤0.01% | 1323 |
|
|
2024
Q2 | $382K | Sell |
5,580
-311
| -5% | -$18.6K | ﹤0.01% | 1131 |
|
|
2024
Q1 | $316K | Sell |
5,891
-472
| -7% | -$25.4K | ﹤0.01% | 1398 |
|
|
2023
Q4 | $339K | Sell |
6,363
-120
| -2% | -$5.85K | ﹤0.01% | 1291 |
|
|
2023
Q3 | $322K | Buy |
6,483
+1,656
| +34% | +$92.6K | ﹤0.01% | 1167 |
|
|
2023
Q2 | $287K | Sell |
4,827
-103
| -2% | -$5.87K | ﹤0.01% | 1301 |
|
|
2023
Q1 | $279K | Sell |
4,930
-1,012
| -17% | -$64.9K | ﹤0.01% | 1255 |
|
|
2022
Q4 | $441K | Buy |
5,942
+505
| +9% | +$34.4K | ﹤0.01% | 1021 |
|
|
2022
Q3 | $324K | Sell |
5,437
-220
| -4% | -$13.2K | ﹤0.01% | 1105 |
|
|
2022
Q2 | $318K | Sell |
5,657
-2,209
| -28% | -$145K | ﹤0.01% | 1184 |
|
|
2022
Q1 | $580K | Sell |
7,866
-1,253
| -14% | -$87.1K | ﹤0.01% | 1190 |
|
|
2021
Q4 | $658K | Buy |
9,119
+1,858
| +26% | +$135K | ﹤0.01% | 1277 |
|
|
2021
Q3 | $556K | Sell |
7,261
-1,407
| -16% | -$113K | ﹤0.01% | 1146 |
|
|
2021
Q2 | $672K | Buy |
8,668
+1,271
| +17% | +$90.4K | ﹤0.01% | 1307 |
|
|
2021
Q1 | $456K | Buy |
7,397
+57
| +0.8% | +$3.61K | ﹤0.01% | 1507 |
|
|
2020
Q4 | $479K | Buy |
7,340
+954
| +15% | +$54.8K | ﹤0.01% | 1300 |
|
|
2020
Q3 | $316K | Buy |
6,386
+160
| +3% | +$8.25K | ﹤0.01% | 1144 |
|
|
2020
Q2 | $297K | Sell |
6,226
-2,435
| -28% | -$117K | ﹤0.01% | 1230 |
|
|
2020
Q1 | $368K | Sell |
8,661
-10,009
| -54% | -$495K | ﹤0.01% | 814 |
|
|
2019
Q4 | $1.1M | Buy |
18,670
+2,441
| +15% | +$133K | 0.01% | 770 |
|
|
2019
Q3 | $830K | Buy |
16,229
+417
| +3% | +$19.9K | ﹤0.01% | 816 |
|
|
2019
Q2 | $669K | Sell |
15,812
-1,629
| -9% | -$70.7K | ﹤0.01% | 906 |
|
|
2019
Q1 | $862K | Buy |
17,441
+2,500
| +17% | +$113K | 0.01% | 831 |
|
|
2018
Q4 | $647K | Sell |
14,941
-2,595
| -15% | -$129K | ﹤0.01% | 856 |
|
|
2018
Q3 | $995K | Buy |
17,536
+1,856
| +12% | +$97.7K | 0.01% | 821 |
|
|
2018
Q2 | $791K | Buy |
15,680
+547
| +4% | +$28.5K | 0.01% | 918 |
|
|
2018
Q1 | $754K | Sell |
15,133
-1,598
| -10% | -$75.1K | ﹤0.01% | 936 |
|
|
2017
Q4 | $688K | Buy |
16,731
+7,283
| +77% | +$255K | ﹤0.01% | 987 |
|
|
2017
Q3 | $281K | Sell |
9,448
-1,776
| -16% | -$54.2K | ﹤0.01% | 1160 |
|
|
2017
Q2 | $372K | Sell |
11,224
-2,797
| -20% | -$87.9K | ﹤0.01% | 1064 |
|
|
2017
Q1 | $415K | Sell |
14,021
-4,147
| -23% | -$113K | ﹤0.01% | 1087 |
|
|
2016
Q4 | $451K | Buy |
+18,168
| New | +$413K | 0.01% | 1127 |
|
|
2016
Q3 | – | Sell |
-8,570
| Closed | -$204K | – | 1485 |
|
|
2016
Q2 | $204K | Buy |
8,570
+168
| +2% | +$4.03K | ﹤0.01% | 1410 |
|
|
2016
Q1 | $200K | Sell |
8,402
-1,589
| -16% | -$38.8K | ﹤0.01% | 1422 |
|
|
2015
Q4 | $278K | Buy |
+9,991
| New | +$251K | ﹤0.01% | 1331 |
|
|
2015
Q3 | – | Sell |
-8,661
| Closed | -$222K | – | 1489 |
|
|
2015
Q2 | $222K | Sell |
8,661
-4,048
| -32% | -$103K | ﹤0.01% | 1458 |
|
|
2015
Q1 | $321K | Sell |
12,709
-1,417
| -10% | -$34.5K | ﹤0.01% | 1426 |
|
|
2014
Q4 | $336K | Sell |
14,126
-12,007
| -46% | -$266K | ﹤0.01% | 1439 |
|
|
2014
Q3 | $514K | Sell |
26,133
-5,920
| -18% | -$122K | 0.01% | 1393 |
|
|
2014
Q2 | $767K | Sell |
32,053
-23,243
| -42% | -$561K | 0.01% | 1309 |
|
|
2014
Q1 | $1.47M | Buy |
+55,296
| New | +$1.31M | 0.02% | 979 |
|
|
2013
Q4 | – | Sell |
-34,507
| Closed | -$602K | – | 1551 |
|
|
2013
Q3 | $602K | Buy |
+34,507
| New | +$597K | 0.01% | 1309 |
|
Other funds holding GMED
VCM
VPM
SC
ProShare Advisors's GMED Position: Q1 2026 in Review
ProShare Advisors increased its Globus Medical (GMED) stake by 0.02% in Q1 2026, buying an estimated $90 and bringing the position to 4,712 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.
ProShare Advisors first reported a position in GMED in Q3 2013 and has held it in 48 quarters since. The position peaked at $1.47M in Q1 2014. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- ProShare Advisors held 4,712 shares of Globus Medical worth $406K as of Q1 2026.
- ProShare Advisors bought 1 Globus Medical share in Q1 2026, an estimated $90.
- Globus Medical made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1172 holding.
- ProShare Advisors first reported a position in Globus Medical in Q3 2013 and has held it in 48 quarters since.
- ProShare Advisors's Globus Medical position peaked at $1.47M in Q1 2014.
- 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.